Top

ISSCA to Host Regenerative Medicine Cell Therapies Symposium at Hotel Hyatt Regency, Istanbul, Turkey

                    ISSCA Istanbul conference: The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium at the Hotel Hyatt Regency in Istanbul, Turkey April 28, 2018. MIAMI, Feb 19, 2018—The International Association for Stem Cell Application (ISSCA) will host its next regenerative medicine symposium at the Hotel Hyatt Regency in Istanbul, Turkey April 28, 2018. The symposium agenda will focus on: Molecular biology Clinical advances in stem cell research Models of treatment in surgical and cosmetic applications, and in clinical conditions Technological advances Application of minimally manipulated stem cells in the physician’s office Stem cells, regenerative medicine and its application in anti-aging medicine, Pain Management and Orthopedics Medical legal issues. Regulatory Pathways Istanbul, the economic, cultural, and historic center of Turkey, is the...

Read More

Global Stem Cells Group Advisory Board Member Amine Rafik, M.D., Ph.D. to speak on the Role of Adipose-Derived Stem Cells in Wound Healing, at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey

                      MIAMI, Feb 19, 2018—Amine Rafik, M.D., Ph.D., a member of the Global Stem Cells Group Advisory Board, will be a keynote speaker at the International Association for Stem Cell Application (ISSCA) Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Rafik will speak on the role of adipose-derived stem cells in regenerative medicine as an attractive alternative to the use of stem cells derived from bone marrow and other sources, due to their abundance in fat and their ability to be easily harvested. [caption id="attachment_16420" align="alignleft" width="194"] Amine Rafik, M.D., Ph.D[/caption] Rafik will present a retrospective review of patients treated for leg ulcers with lipofilling between 2011 -  2014 at the National Centre for Burns and Plastic Surgery, University Hospital. Ibn-Rochd Casablanca, Morocco. Rafik’s lecture will...

Read More

Leslie Mesen, M.D., Medical Director of Stem Cell Center Costa Rica, to Speak on the Potential of Mesenchymal Stem Cell Treatments for Wound Healing at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey

                          MIAMI, Feb 19, 2018—Leslie Mesen, M.D., a leader in the field of anti-aging medicine in Latin America and medical director of Global Stem Cells Group affiliate Stem Cell Center in Escazu, Costa Rica, will be a keynote speaker at the International Association for Stem Cell Application (ISSCA) Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. [caption id="attachment_16423" align="alignleft" width="181"] Leslie Mesen, M.D.[/caption] Mesen will present a lecture detailing the wound-healing potential of mesenchymal stem cell procedures—both SVF and BMAC---in wounds when no other treatment options exist. Mesen will discuss his experience successfully treating a serious foot wound using mesenchymal stem cells in a 45-year-old patient. The wound was the result of a 30.000-volt shock caused when the patient came in contact with a high-tension...

Read More

ISSCA Announces Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018

            (Image: Istanbul, Turkey) The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium in Istanbul, Turkey April 28, 2018. MIAMI, Feb 14, 2018—The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium in Istanbul, Turkey April 28, 2018. The symposium will focus on new advances in cell therapies. The Istanbul international symposium is part of ISSCA’s mission to support a shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed...

Read More

Global Stem Cells Group to Launch Regenerative Medicine Training Program for Mexico at Congreso Internacional de Medicina Antienvejecimiento y Longevidad

        (Image: Regenerative Medicine Training Program for Mexico) MIAMI, Feb. 14, 2018— Global Stem Cells Group, a world leader in stem cell and regenerative medicine, will launch the organization’s complete Regenerative Medicine Training Program  for Mexico at the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad (Congress in Anti-Aging and Longevity Medicine) to be held February 16 - 18, 2018 in Mexico City. The training course will be held in Mexico City April 13 - 14, 2018. The “Practical Course of Cell Therapies in a Clinical Environment” is a two-day, hands-on training course that provides physician attendees with the intellectual property of 22 proprietary protocols that allow treatment procedures for degenerative and aesthetic conditions and diseases in-office, as well as step-by-step videos of each protocol. Course attendees will acquire the skills...

Read More

Global Stem Cells Group CEO Benito Novas to be a Keynote Speaker at Congreso Internacional de Medicina Antienvejecimiento y Longevidad Feb. 16-18, 2018

                              Benito Novas, Global Stem Cells Group CEO MIAMI, Feb. 14, 2018— Global Stem Cells Group founder and CEO Benito Novas will be a keynote speaker at the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad (Congress in Anti-Aging and Longevity Medicine) February 16 – 18, 2018 in Mexico City. The conference is organized by The Institute of Anti-Aging and Longevity Medicine, the leading anti-aging and regenerative medicine society in Mexico. Novas, a global entrepreneur and medical marketing professional in the fields of biotechnology, life sciences, and healthcare development, will share his expertise on the latest marketing tools for managing a medical practice. Topics will include social media strategies and tools for promoting physician practices, and how to design Google and Facebook ads that generate targeted leads and...

Read More

Global Stem Cells Group to Sponsor Congreso Internacional de Medicina Antienvejecimiento y Longevidad Feb. 16-18, 2018

                        (Image: Hotel Reforma, Mexico City) MIAMI, Feb. 14, 2018— Global Stem Cells Group, a world leader in stem cell and regenerative medicine, will sponsor the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad (Congress in Anti-Aging and Longevity Medicine) to be held February 16 – 18, 2018 in Mexico City. This will be the third consecutive year GSCG is sponsoring the Congress. Global Stem Cells Group founder and CEO Benito Novas will join healthcare professionals from around the world for the event. Anti-aging medicine focuses on early detection, prevention, treatment, and regeneration for conditions related to advanced age and promotes. innovative therapy and protocol development for the therapeutic management of aging and elderly patients. Four-hundred participants are expected to attend. [caption id="attachment_16392" align="alignright" width="286"]      Instituto de...

Read More
Share

Global Stem Cells Group names Mehmet Veli Karaaltın, M.D. to Advisory Board

                        (Image: Mehmet Veli Karaaltın, M.D.) MIAMI, Jan. 18, 2018—Global Stem Cells Group CEO Benito Novas has named Mehmet Veli Karaaltın, M.D., Associate Professor of Plastic, Aesthetic, and Reconstructive Surgery, (European Board Certified), and hand surgery, head, and maxillofacial surgery specialist to the GSCG Advisory Board Faculty. Karaaltın practices in Istanbul, Turkey. Born in Iraq-Kirkuk in 1972, Karaaltın moved to the United States with his family, living in West Lafayette, Indiana and Los Angeles until 1988, when he moved to Istanbul. After graduating from Istanbul University’s Cerrahpaşa English Medical Faculty, Karaaltın received a national examination from Hacettepe University in Ankara, Turkey, where he was 12th out of 25000 doctoral candidates.  In 2012, he passed and completed all ID exams required by the European Society of Plastic Surgery. He ​​is a member...

Read More

ISSCA President Daeyong Kim, Ph.D. Announces Next Chapter Meeting to be Held Jan. 24 – 26, 2018 in Seoul, Korea

              ISSCA President Daeyong Kim, Ph.D., and Vice President Benito Novas to hold next ISSCA chapter meeting in Seoul, Korea Jan. 24-26, 2018. MIAMI, Jan. 18, 2018— ISSCA President Daeyong Kim, Ph.D. has announced the next chapter meeting will be held Jan. 24 – 26, 2018 in Seoul, Korea. The meeting will be held by Kim and ISSCA Vice President Benito Novas and will address all ISSCA chapter directors and board members. ISSCA Chapter directors from the U.S., Costa Rica, Argentina, Spain, and Morocco will be in attendance. During the three-day event, chapter directors will receive training in the latest regenerative medicine clinical application protocols as well as applications for manipulating and harvesting stem cells in lab conditions. ISSCA will also establish strategies for 2018, focusing on promoting excellence and...

Read More

ISSCA President Daeyong Kim, Ph.D. Names Junaid Sayed, M.D. President of ISSCA’s U.S. Chapter

                          (Image: Junaid A. Syed, M.D.) ISSCA President Daeyong Kim, Ph.D., has named Junaid Sayed, M.D. president of ISSCA’s U.S. chapter. MIAMI, Jan. 18, 2018—International Society for Stem Cell Application (ISSCA) President Daeyong Kim, Ph.D., has named Junaid Sayed, M.D. president of ISSCA’s U.S. chapter. Sayed is Board Certified physician with extensive training in aesthetic medicine. As president of the U.S. chapter, Sayed will represent and promote ISSCA activities the USA, including ISSCA’s Stem Cell Certification Training and Stem Cell Conference events. He will also share the latest information on regenerative medicine clinical applications with the U.S, medical community. “We are happy to have Dr. Sayed represent ISSCA in the U.S., and as a collaborator in our efforts to introduce new clinical applications to the medical community,” says Kim. “He brings a wealth...

Read More
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LnlvdXR1YmUuY29tL2VtYmVkL2phRHdSdk95SEs4P3JlbD0wJmF1dG9wbGF5PTEiZnJhbWVib3JkZXI9IjAiIGFsbG93ZnVsbHNjcmVlbj48L2lmcmFtZT4=
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LnlvdXR1YmUuY29tL2VtYmVkL0FBdUpNaTFIZzZzP3JlbD0wJmFtcDtzaG93aW5mbz0wIiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LnlvdXR1YmUuY29tL2VtYmVkL2phRHdSdk95SEs4P3JlbD0wJmF1dG9wbGF5PTEiZnJhbWVib3JkZXI9IjAiIGFsbG93ZnVsbHNjcmVlbj48L2lmcmFtZT4=